Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY). In a filing disclosed on February 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in DENTSPLY SIRONA stock on January 8th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 2/3/2025.
• Purchased $15,001 – $50,000 in shares of CACI International (NYSE:CACI) on 1/31/2025.
• Purchased $50,001 – $100,000 in shares of Hawaiian Electric Industries (NYSE:HE) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Agios Pharmaceuticals (NASDAQ:AGIO) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Paragon 28 (NYSE:FNA) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of U.S. Physical Therapy (NYSE:USPH) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/29/2025.

DENTSPLY SIRONA Trading Up 2.2 %

Shares of NASDAQ:XRAY opened at $18.77 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $34.91. The stock has a market cap of $3.73 billion, a price-to-earnings ratio of -9.07, a PEG ratio of 1.83 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a 50-day moving average price of $19.04 and a 200-day moving average price of $22.04.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.41%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on XRAY shares. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Evercore ISI restated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC restated a “buy” rating and issued a $25.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, UBS Group reduced their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Ten investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $25.85.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of XRAY. Tower Research Capital LLC TRC raised its stake in shares of DENTSPLY SIRONA by 602.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 26,372 shares of the medical instruments supplier’s stock worth $501,000 after buying an additional 22,617 shares during the period. MetLife Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 7.0% during the 4th quarter. MetLife Investment Management LLC now owns 112,113 shares of the medical instruments supplier’s stock worth $2,128,000 after buying an additional 7,351 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 21.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock worth $130,045,000 after buying an additional 1,230,944 shares during the period. First Trust Advisors LP raised its stake in shares of DENTSPLY SIRONA by 4.2% during the 4th quarter. First Trust Advisors LP now owns 270,363 shares of the medical instruments supplier’s stock worth $5,131,000 after buying an additional 10,980 shares during the period. Finally, CANADA LIFE ASSURANCE Co raised its stake in shares of DENTSPLY SIRONA by 14.7% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 212,681 shares of the medical instruments supplier’s stock worth $4,034,000 after buying an additional 27,246 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.